Tag: Trio investors in MyoKardia
New Biotech Firm Raises $300 Million with Focus on Heart Disease
**New Biotech Firm Raises $300 Million with Focus on Heart Disease**In a bold move that has sent shockwaves through the biotech industry, MyoKardia's former...
BREAKING NEWS
Frustration Among Long-Covid Patients Over Lack of Federal Treatment Research –...
Millions of Americans Struggle with Long CovidThe pandemic has left a trail of destruction in its wake, not only claiming lives but also leaving...
